These markers efficiently reflect blood glucose status, but they cannot characterize T2DM patients at a more detailed level, for example with regards to pancreatic function, peripheral effects of insulin and progression of secondary complications of the disease. The gene discussed is INS; the disease is type 2 diabetes mellitus.